628 related articles for article (PubMed ID: 29895749)
1. Functional Regulation of PPARs through Post-Translational Modifications.
Brunmeir R; Xu F
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895749
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
[TBL] [Abstract][Full Text] [Related]
3. Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons.
Cimini A; Benedetti E; Cristiano L; Sebastiani P; D'Amico MA; D'Angelo B; Di Loreto S
Neuroscience; 2005; 130(2):325-37. PubMed ID: 15664689
[TBL] [Abstract][Full Text] [Related]
4. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma.
Li AC; Binder CJ; Gutierrez A; Brown KK; Plotkin CR; Pattison JW; Valledor AF; Davis RA; Willson TM; Witztum JL; Palinski W; Glass CK
J Clin Invest; 2004 Dec; 114(11):1564-76. PubMed ID: 15578089
[TBL] [Abstract][Full Text] [Related]
5. Three peroxisome proliferator-activated receptor isotypes from each of two species of marine fish.
Leaver MJ; Boukouvala E; Antonopoulou E; Diez A; Favre-Krey L; Ezaz MT; Bautista JM; Tocher DR; Krey G
Endocrinology; 2005 Jul; 146(7):3150-62. PubMed ID: 15790725
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological Blockade of PPAR Isoforms Increases Conditioned Fear Responding in the Presence of Nociceptive Tone.
Gaspar JC; Okine BN; Llorente-Berzal A; Roche M; Finn DP
Molecules; 2020 Feb; 25(4):. PubMed ID: 32102354
[TBL] [Abstract][Full Text] [Related]
7. The Endocannabinoid System and PPARs: Focus on Their Signalling Crosstalk, Action and Transcriptional Regulation.
Iannotti FA; Vitale RM
Cells; 2021 Mar; 10(3):. PubMed ID: 33799988
[TBL] [Abstract][Full Text] [Related]
8. [PPARs: physiological functions and pharmacological roles of agonists in human diseases. Note II].
Filip-Ciubotaru F; Manciuc C; Grigore C; Foia L
Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):240-7. PubMed ID: 23077903
[TBL] [Abstract][Full Text] [Related]
9. A PPARs cross-talk concertedly commits C6 glioma cells to oligodendrocytes and induces enzymes involved in myelin synthesis.
Leisewitz AV; Urrutia CR; Martinez GR; Loyola G; Bronfman M
J Cell Physiol; 2008 Nov; 217(2):367-76. PubMed ID: 18543250
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory reaction versus endogenous peroxisome proliferator-activated receptors expression, re-exploring secondary organ complications of spontaneously hypertensive rats.
Sun L; Ke Y; Zhu CY; Tang N; Tian DK; Gao YH; Zheng JP; Bian K
Chin Med J (Engl); 2008 Nov; 121(22):2305-11. PubMed ID: 19080338
[TBL] [Abstract][Full Text] [Related]
11. Zinc finger protein 407 overexpression upregulates PPAR target gene expression and improves glucose homeostasis in mice.
Charrier A; Wang L; Stephenson EJ; Ghanta SV; Ko CW; Croniger CM; Bridges D; Buchner DA
Am J Physiol Endocrinol Metab; 2016 Nov; 311(5):E869-E880. PubMed ID: 27624101
[TBL] [Abstract][Full Text] [Related]
12. The story so far: post-translational regulation of peroxisome proliferator-activated receptors by ubiquitination and SUMOylation.
Wadosky KM; Willis MS
Am J Physiol Heart Circ Physiol; 2012 Feb; 302(3):H515-26. PubMed ID: 22037188
[TBL] [Abstract][Full Text] [Related]
13. Δ
Hirao-Suzuki M; Takeda S; Watanabe K; Takiguchi M; Aramaki H
Arch Biochem Biophys; 2019 Feb; 662():219-225. PubMed ID: 30553767
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases.
Monsalve FA; Pyarasani RD; Delgado-Lopez F; Moore-Carrasco R
Mediators Inflamm; 2013; 2013():549627. PubMed ID: 23781121
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome-proliferator-activated receptors and the control of levels of prostaglandin-endoperoxide synthase 2 by arachidonic acid in the bovine uterus.
Sheldrick EL; Derecka K; Marshall E; Chin EC; Hodges L; Wathes DC; Abayasekara DR; Flint AP
Biochem J; 2007 Aug; 406(1):175-83. PubMed ID: 17516915
[TBL] [Abstract][Full Text] [Related]
16. Modulation of PPAR activity via phosphorylation.
Burns KA; Vanden Heuvel JP
Biochim Biophys Acta; 2007 Aug; 1771(8):952-60. PubMed ID: 17560826
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions.
Wagner KD; Wagner N
Pharmacol Ther; 2010 Mar; 125(3):423-35. PubMed ID: 20026355
[TBL] [Abstract][Full Text] [Related]
18. Identification, organ expression and ligand-dependent expression levels of peroxisome proliferator activated receptors in grass carp (Ctenopharyngodon idella).
He S; Liang XF; Qu CM; Huang W; Shen D; Zhang WB; Mai KS
Comp Biochem Physiol C Toxicol Pharmacol; 2012 Mar; 155(2):381-8. PubMed ID: 22079418
[TBL] [Abstract][Full Text] [Related]
19. Cellular and pharmacological selectivity of the peroxisome proliferator-activated receptor-beta/delta antagonist GSK3787.
Palkar PS; Borland MG; Naruhn S; Ferry CH; Lee C; Sk UH; Sharma AK; Amin S; Murray IA; Anderson CR; Perdew GH; Gonzalez FJ; Müller R; Peters JM
Mol Pharmacol; 2010 Sep; 78(3):419-30. PubMed ID: 20516370
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor beta/delta as a therapeutic target for metabolic diseases.
Bedu E; Wahli W; Desvergne B
Expert Opin Ther Targets; 2005 Aug; 9(4):861-73. PubMed ID: 16083348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
